Precision treatment for metastatic non-small cell lung cancer: A conceptual overview.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33526466.
- Also identified by DOI 10.3949/ccjm.88a.19148.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent developments in precision oncology have increased the complexity of diagnostic and therapeutic decisions. Here, we broadly review the field of precision oncology and discuss common mutational drivers in non-small cell lung cancer (NSCLC) that directly relate to the diagnosis, evaluation, and treatment of patients with metastatic disease.
Medical subject headings
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms